Aim: To assess stimulant adherence among children/adolescents with attention-deficit/hyperactivity
disorder (ADHD) augmenting stimulants with guanfacine extended-release (GXR). Patients & methods: Inclusion criteria: 6–17 years, ≥1 ADHD diagnosis, ≥1 ...